CCCC
C4 Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.89
+4.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.44x
- Price / sales
- 10.15x
- Price / cash flow
- -4.19x
Enterprise value
- Enterprise value
- $158.7M
- EV / sales
- 4.53x
- EV / EBITDA
- -1.59x
- EV / EBIT
- -1.42x
- Market cap
- $355.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026